Attawar Sandeep, Manoly Imthiaz, Shah Unmil
Institute of Heart and Lung Transplant, Krishna Institute of Medical Sciences, Hyderabad, Telangana India.
Cardiothoracic Surgery , Burjeel Hospitals, Abu Dhabi, United Arab Emirates.
Indian J Surg. 2023 Jan 16:1-12. doi: 10.1007/s12262-023-03663-w.
Lung transplantation is gaining widespread acceptance as the preferred therapeutic option for selected cases of end-stage lung disease in India. The indications of lung transplantation are increasing, with better post-operative survival, including the COVID affected lung, if we choose our patients well. The national acceptance of expanded criteria in lung donation, streamlining of the process of lung transplantation by governmental, and non-governmental organizations and significant increase in the number of organ donations in India have strengthened the lung transplantation program within the country. Through this article, we describe a brief history, the process, and our experience of lung transplantation since we started our program in 2017 until date.
在印度，肺移植作为终末期肺病特定病例的首选治疗方案正得到广泛认可。肺移植的适应症不断增加，术后生存率提高，如果我们能精心挑选患者，包括受新冠影响的肺部患者。印度在肺捐赠方面对扩大标准的全国性接受、政府和非政府组织对肺移植流程的简化以及器官捐赠数量的显著增加，都加强了国内的肺移植项目。通过本文，我们描述了自2017年启动项目至今肺移植的简要历史、流程及我们的经验。
